These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25660673)

  • 1. Extracutaneous manifestations and long-term sequelae of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Vercueil A; Walsh S
    Br J Dermatol; 2015 Feb; 172(2):312. PubMed ID: 25660673
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive bronchial obstruction associated with toxic epidermal necrolysis.
    Minamihaba O; Nakamura H; Sata M; Inage M; Shirakabe M; Tanida H; Osada Y; Kondo S; Tomoike H
    Respirology; 1999 Mar; 4(1):93-5. PubMed ID: 10339737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchial obstruction due to respiratory mucosal sloughing in toxic epidermal necrolysis.
    Dasgupta A; O'Malley J; Mallya R; Williams JG
    Thorax; 1994 Sep; 49(9):935-6. PubMed ID: 7940439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Prendiville JS; Hebert AA; Greenwald MJ; Esterly NB
    J Pediatr; 1989 Dec; 115(6):881-7. PubMed ID: 2585222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual manifestation of Stevens-Johnson syndrome involving the respiratory and gastrointestinal tract.
    Edell DS; Davidson JJ; Muelenaer AA; Majure M
    Pediatrics; 1992 Mar; 89(3):429-32. PubMed ID: 1741216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing the ADR of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Lian BS; Lee HY
    Expert Opin Drug Saf; 2022 Aug; 21(8):1039-1046. PubMed ID: 35878014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Wilkins J; Morrison L; White CR
    Dermatol Clin; 1992 Jul; 10(3):571-82. PubMed ID: 1617814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulvovaginal manifestations in Stevens-Johnson syndrome and toxic epidermal necrolysis: Prevention and treatment.
    O'Brien KF; Bradley SE; Mitchell CM; Cardis MA; Mauskar MM; Pasieka HB
    J Am Acad Dermatol; 2021 Aug; 85(2):523-528. PubMed ID: 31437544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fromowitz JS; Ramos-Caro FA; Flowers FP;
    Int J Dermatol; 2007 Oct; 46(10):1092-4. PubMed ID: 17910723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Mockenhaupt M
    Expert Rev Clin Immunol; 2011 Nov; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent blisters in a case of resolving Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Chuang YN; Ho YY; Chiu TM
    Indian J Dermatol Venereol Leprol; 2014; 80(6):546-7. PubMed ID: 25382518
    [No Abstract]   [Full Text] [Related]  

  • 16. Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Sotozono C; Yamauchi N; Maeda S; Kinoshita S
    Am J Ophthalmol; 2014 Nov; 158(5):983-93. PubMed ID: 25036881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchopulmonary distress associated with toxic epidermal necrolysis.
    Timsit JF; Mion G; Rouyer N; Le Gulluche Y; Carsin H
    Intensive Care Med; 1992; 18(1):42-4. PubMed ID: 1578047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ukponmwan CU; Njinaka I; Ehimiyen ET
    Trop Doct; 2010 Jul; 40(3):167-8. PubMed ID: 20555046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.